Pyrrolcarboxamide derivatives for the inhibition of ERK5
US10344017B2 · kind B2 · utility
1Cited by
1References
20Claims
0Family size
Inventors
Key dates
| Filing date | Sep 18, 2015 |
| Grant date | Jul 9, 2019 |
| Priority date | — |
| Expiry date | Sep 18, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides compounds of formula (I) or a tautomer, stereoisomer, N-oxide, pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the prophylaxis or treatment of a disease state or condition mediated by ERK5, in particular cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.